The new Myval THV: only good news?

Editorial

Jul 18
The new Myval THV: only good news?
Philippe Pibarot, Eric Van Belle
This study compares the long-term durability of balloon-expandable and self-expanding transcatheter heart valves, highlighting the need for long-term outcome data and ongoing research to enhance valve durability.
free

Original Research

Jul 17
Myval long-term durability
Akash Jain, Ignacio J. Amat-Santos, et al.
The study evaluated the 4-year durability of the Myval series, a balloon-expandable TAVI system, and found acceptable valve durability, low haemodynamic deterioration, and comparable performance to contemporary TAVI systems.
Myval long-term durability

Expert Review

Jul 16
Robotics in structural heart interventions
Xiang Chen, Maurizio Taramasso, et al.
The article discusses the growing use of robotics in cardiovascular surgery and interventions, with a focus on the potential application in structural heart interventions, highlighting both the advantages and challenges.
Robotics in structural heart interventions

Original Research

Jul 15
IA- versus SA-SEV in small aortic annuli
Masanori Yamamoto, Kentaro Hayashida, et al.
This retrospective study compared early clinical outcomes, including echocardiographic parameters, between intra-annular and supra-annular self-expanding valves after TAVI in patients with small aortic annulus, finding similar results except for slightly higher mean pressure gradient with intra-annular valves.
IA- versus SA-SEV in small aortic annuli

Editorial

Jul 15
Comparative TAVI studies
Liesbeth Rosseel, Ole De Backer, et al.
This study compared the performance of the intra-annular Navitor and supra-annular Evolut FX transcatheter aortic valves in patients with small aortic annuli, finding no significant differences in short-term valve hemodynamics and clinical outcomes.
free

Research Correspondence

Jul 11
Restenosis patterns after DCBs: serial OCT analysis
Kazuki Matsuda, Tetsuo Sasano, et al.
This retrospective, observational study examined the underlying morphological findings in lesions treated with target lesion revascularization after initial drug-coated balloon treatment for de novo coronary artery disease.
Restenosis patterns after DCBs: serial OCT analysis

Editorial

Jul 10
Antithrombotic therapy post-TAVI and microembolism
George Dangas, Johny Nicolas
TAVI can lead to cerebral microembolization and new lesions on DW-MRI. Current single antiplatelet therapy may not be optimal for all patients, and future research should explore personalized antithrombotic strategies and embolic protection devices.
free
Meet Cory, your AI Assistant!
Enhance your reading experience and get deeper insights on complex topics.
Learn more


“Stone whisper” technique

Flashlight

Jul 7
“Stone whisper” technique
Maximilian Will, Konstantin Schwarz, et al.
A 74-year-old male with heart failure and left ventricular ejection fraction of 40% presented with exertional chest pain and dyspnea. Coronary angiography revealed a chronic total occlusion in a large side branch of the left anterior descending artery, which was successfully treated using the 'stone whisper technique' of intravascular lithotripsy.

Receive our newsletter
Subscribe banner

Original Research

Jul 9
Antithrombotic strategies for post-TAVI microembolism
Victor Alfonso Jimenez Diaz, Andres Iñiguez Romo, et al.
In patients without indication for oral anticoagulation undergoing TAVI, dual antiplatelet therapy did not reduce the incidence of new cerebral lesions on MRI compared to oral anticoagulation, but resulted in smaller lesion volumes.
Antithrombotic strategies for post-TAVI microembolism

Debate

Jul 8
Re-evaluating colchicine benefits and recommendations
Kevin R. Bainey, Xavier Rossello
A large randomized clinical trial in patients with myocardial infarction yielded neutral results for the use of colchicine, raising concerns about its true clinical benefit in patients with atherosclerotic cardiovascular disease.
Re-evaluating colchicine benefits and recommendations

NEW ISSUE

Jul 7
A new issue of EuroIntervention

Robotics in structural heart interventions; debating colchicine recommendations; the AUREA trial; intra- vs supra-annular self-expanding valves in small aortic annuli; Myval durability at 4 years; restenosis patterns after drug-coated balloon PCI; news from the EAPCI; and more... 

A new issue of EuroIntervention

Letter to the Editor

Jul 4
REPLY: Completeness or complexity?
Claudio Laudani, Davide Capodanno, et al.
This manuscript discusses the challenges in assessing the impact of complete revascularization in STEMI patients, highlighting the limitations of available data and the importance of considering disease complexity.
free

Letter to the Editor

Jul 3
LETTER: Completeness or complexity?
Alessandro Sticchi, Giuseppe Biondi-Zoccai
The study by Laudani et al. examined complete revascularization strategies in acute myocardial infarction with multivessel disease, but the authors raise concerns about the potential dilution or exaggeration of true treatment effects due to heterogeneous trial designs and patient populations.
free

Original Research

Jul 2
Chimney stenting for redo-TAVI
Alessandro Beneduce, Dariusz Dudek, et al.
This ex vivo study evaluated the feasibility and outcomes of chimney stenting during redo-TAVI, finding that interactions between the coronary stents and the index TAV frames or aortic wall led to stent distortion and underexpansion, which could compromise procedural efficacy and future coronary access.
Chimney stenting for redo-TAVI

Trending articles
225

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.05

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved